Journals / Balkan Medical Journal / 2012 / Cilt: 29 - Sayı: 2

Benign ve malign tiroid nodüllerinin gelişiminde insulin-Like growth factor 1’in rolü

The role of insulin-like growth factor 1 in the development of benign and malignant thyroid nodules

Pages
133–138
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Allred 8-unit scores were higher in benign nodules (n=89; 4.1±2.3) and papillary carcinomas (n=7; 6.7±1.3), than in extranodular healthy tissues in the same patients (2.3±2.3 and 3.3±1.9, respectively); and higher in papillary carcinomas than in benign nodules, when the scores were compared to each other (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: This study aims to investigate the role of IGF-1 in the development of nodular thyroid disease.Material and Methods: A total number of 100 consecutive patients operated for nodular thyroid disease in our institution were included in this prospective study.
📊
Key Findings & Data:In addition to classical pathological examinations, nodules and extranodular healthy tissues were sampled and immunochemically stained for IGF-1.
💡
Conclusion & Impact:Allred 8-unit scores were higher in benign nodules (n=89; 4.1±2.3) and papillary carcinomas (n=7; 6.7±1.3), than in extranodular healthy tissues in the same patients (2.3±2.3 and 3.3±1.9, respectively); and higher in papillary carcinomas than in benign nodules, when the scores were compared to each other (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: This study aims to investigate the role of IGF-1 in the development of nodular thyroid disease.Material and Methods: A total number of 100 consecutive patients operated for nodular thyroid disease in our institution were included in this prospective study. In addition to classical pathological examinations, nodules and extranodular healthy tissues were sampled and immunochemically stained for IGF-1. The materials were independently evaluated using an Allred Scoring System ranging from 0 to 8. If the score was ≥1, the tissue was accepted as IGF-1 positive. Results: IGF-1 positivity was observed in 88% and 58% of the samples obtained from nodules and extranodular healthy tissues, respectively. Allred 8-unit scores were higher in benign nodules (n=89; 4.1±2.3) and papillary carcinomas (n=7; 6.7±1.3), than in extranodular healthy tissues in the same patients (2.3±2.3 and 3.3±1.9, respectively); and higher in papillary carcinomas than in benign nodules, when the scores were compared to each other (p

Özet

Amaç: Bu çalışmanın amacı tiroid nodüllerinin gelişmesinde IGF-1’in rolünü araştırmaktır. Yöntem: Kliniğimizde nodüler tiroid hastalığı sebebiyle ameliyat edilen ardışık 100 hasta çalışmaya dahil edilmiştir. Bu hastalardan alınan tiroid dokuları rütin patolojik değerlendirmelerin yanısıra, nodüller ve nodül dışı alanlar ayrı ayrı olmak üzere IGF-1 için immünokimyasal olarak boyanmışlardır. Boyanan materyaller iki ayrı tecrübeli patolog tarafından Allred Skorlama Sistemi kullanılarak 0 dan 8’e kadar puanlanarak değerlendirilmiştir. Skor 1’in üzerindeki tüm dokular IGF-1 açısından pozitif kabül edilmişlerdir. Bulgular: IGF-1, nodüllerden alınan örneklerde %88 oranında pozitif çıkarken, nodül dışı tiroid dokularından alınan örneklerde %58 oranında pozitif çıkmıştır. Allred skoru gerek selim nodüllerde (n=89, 4.1±2.3) gerekse papiller kanser saptanan nodüllerde (n=7; 6.7±1.3), aynı hastaların nodül dışı dokularından alınan örneklere oranla anlamlı düzeyde yüksek çıkmıştır (sırasıyla 2.3±2.3 ve 3.3±1.9). Bunun yanında papiller kanser saptanan dokuların Allred skorları selim nodüllerin skorlarından anlamlı düzeyde yüksek çıkmıştır (bahsedilen tüm karşılaştırmalarda p

🔖

Cite This Article

VURAL, S., KEMENT, M., YAVUZER, D., BAŞTÜRK, E., ILIKSU, H. G., KARADAYI, A., GEZEN, C., ÖNCEL, M. (2022). Benign ve malign tiroid nodüllerinin gelişiminde insulin-Like growth factor 1’in rolü. Balkan Medical Journal, Cilt: 29 - Sayı: 2, 133–138. https://ajindex.com/articles/461695

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Gharib H, Papini E. Thyroid nodules: clinical importance, assessment, and treatment. Endocrinol Metab Clin North Am 2007
  2. 35 [CrossRef] 2. Krohn K, Führer D, Bayer Y, Eszlinger M, Brauer V, Neumann S, et al. Molecular Pathogenesis of euthyroid and toxic multinodular goiter. Endocr Rev 2005
  3. [CrossRef] 3. Koh KB, Chang KW. Carcinoma in multinodular goiter. Brit J Surg 1992
  4. [CrossRef] 137 Balkan Med J 2012
  5. 8 Baştürk et al. IGF-1 in the Development of Thyroid Nodules 4. Bradly DP, Reddy V, Prinz RA, Gattuso P. Incidental papillary carcinoma in patients treated surgically for benign thyroid diseases. Surgery 2009
  6. [CrossRef] 5. Rinderknecht E, Humbel RE. The amino acid sequence of human insulin-like growth factor I and its structural homology with proinsulin. J Biol Chem 1978
  7. Jones JI, Clemmons DR. Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 1995
  8. [CrossRef] 7. Schernhammer ES, Holly JM, Hunter DJ, Pollak MN, Hankinson SE. Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in The Nurses Health Study II. Endocr Relat Cancer 2006
  9. [CrossRef] 8. Van der Laan BF, Freeman JL, Asa SL. Expression of growth factors and growth factor receptors in normal and tumorous human thyroid tissues. Thyroid 1995
  10. [CrossRef] 9. Bechtner G, Schopohl D, Rafferzeder M, Gärtner R, Welsch U. Stimulation of thyroid cell proliferation by epidermal growth factor is different from cell growth induced by thyrotropin or insulin-like growth factor I. Eur J Endocrinol 1996
  11. [CrossRef] 10. Nakahashi K, Kitahori Y, Konishi N, Ohnishi T, Sugimura M, Hiasa Y. Establishment of a rat thyroid carcinoma cell line in vitro demonstrating high DNA synthesis in response to insulin-like growth factor I. Cancer Letters 1996
  12. [CrossRef] 11. Hsiao PJ, Tsai JH. Increased insulin-like growth factor-1 receptors in thyroid tissues of Graves’ disease. J Formos Med Assoc 1994
  13. Chakravarty G, Santillan AA, Galer C, Adams HP, El-Naggar AK, Jasser SA, et al. Phosphorylated insulin like growth factor-I receptor expression and its clinico-pathological significance in histologic subtypes of human thyroid cancer. Exp Biol Med (Maywood) 2009
  14. [CrossRef] 13. Maiorano E, Ambrosi A, Giorgino R, Fersini M, Pollice L, Ciampolillo A. Insulin-like growth factor 1 (IGF-1) in multinodular